China Regenerative Medicine International Limited(HK:8158)
HK$0.24-0.00 (-0.42%)
HK:8158
China Regenerative Medicine International Limited financials statements
HK$0.24
At close:-0.00 (-0.42%)
Want to see HK:8158 full AI Analyst Report?
China Regenerative Medicine International Limited (8158) Income Statement
0 Followers
China Regenerative Medicine International Limited Income Statement
Last quarter (Q2 2026), China Regenerative Medicine International Limited's total revenue was HK$41.73M, an increase of 204.73% from the same quarter last year. In Q2, China Regenerative Medicine International Limited's net income was HK$4.62M. See China Regenerative Medicine International Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| HK$ 72.06M | HK$ 90.62M | HK$ 69.49M | HK$ 41.54M | HK$ 282.90M | |
| HK$ 41.92M | HK$ 57.65M | HK$ 19.42M | HK$ 37.62M | HK$ 67.73M | |
| HK$ 43.51M | HK$ 38.77M | HK$ 128.54M | HK$ 25.82M | HK$ 8.77M | |
| Depreciation and Amortization | HK$ 9.86M | HK$ 10.96M | HK$ 11.32M | HK$ 5.39M | HK$ 78.00K |
| HK$ 8.26M | HK$ 29.84M | HK$ -95.40M | HK$ 9.92M | HK$ 65.11M | |
| HK$ -1.59M | HK$ 18.88M | HK$ -109.11M | HK$ 12.29M | HK$ 58.96M | |
| HK$ 16.78M | HK$ -1.13M | HK$ 1.41M | HK$ -4.02M | HK$ 5.33M | |
| HK$ 15.19M | HK$ 17.75M | HK$ -107.70M | HK$ 8.27M | HK$ 64.29M | |
| HK$ 27.52M | HK$ 17.75M | HK$ -107.70M | HK$ 4.55M | HK$ 51.83M | |
| Per Share Metrics | |||||
| Basic EPS | HK$ 0.09 | HK$ 0.06 | HK$ -0.38 | HK$ 0.02 | HK$ 0.18 |
| Diluted EPS | HK$ 0.09 | HK$ 0.06 | HK$ -0.38 | HK$ 0.02 | HK$ 0.18 |
| Weighted Average Shares Outstanding | 304.25M | 304.25M | 286.41M | 285.43M | 285.43M |
| Weighted Average Shares Outstanding (Diluted) | 304.25M | 304.25M | 286.41M | 285.43M | 285.43M |
Currency in HKD

